Titan Medical
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Titan Medical generated cash of -$36,617,000, which is less than the previous year. Cash used in financing activities reached the amount of $44,209,000 last year. Net change in cash is therefore $6,837,000.
Cash Flow
| 2012 | -7.75M | -107.72K | 2.71M |
|---|---|---|---|
| 2013 | -7.70M | -48.93K | 5.86M |
| 2014 | -12.87M | -7.88M | 44.47M |
| 2015 | -34.32M | 7.63M | 11.71M |
| 2016 | -35.19M | -165.02K | 28.50M |
| 2017 | -19.08M | -204.83K | 41.08M |
| 2018 | -41.39M | -420.58K | 27.15M |
| 2019 | -45.96M | -458.03K | 35.76M |
| 2020 | -845.11K | -599.36K | 26.09M |
| 2021 | -36.61M | -755K | 44.20M |
TMDI Cash Flow Statement (2012 – 2021)
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 25.46M | 814.49K | 11.47M | 26.13M | 4.33M | 11.19M | 26.16M | 2.44M | 4.33M | 9.78M |
Operating activities | ||||||||||
Net income | -14.85M | -24.18M | -41.90M | -22.63M | -33.58M | -23.32M | -41.41M | -13.45M | -9.07M | -7.76M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 699K | 236.84K | 32.55K | 29.04K | 17.36K | 24.64K | 32.38K | 23.66K | 289.47K | 132.65K |
Stock-based compensation expense | 4.03M | 1.09M | 1.65M | 1.50M | 1.43M | 862.19K | 428.81K | 595.81K | 586.98K | 336.46K |
| Deferred income tax benefit | 4.03M | 1.09M | 1.65M | 1.50M | 1.43M | 862.19K | 428.81K | 595.81K | 586.98K | 336.46K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -10.02M | 0 | 0 | 0 | -504.05K | -1.02M | -133.04K | -605.52K | 36.15K | 485.16K |
Inventories | -1.08M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 1.08M | 0 | 4.96M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by operating activities | -36.61M | -845.11K | -45.96M | -41.39M | -19.08M | -35.19M | -34.32M | -12.87M | -7.70M | -7.75M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -7.75M | 0 | 0 |
Investments In Property Plant And Equipment | -755K | -599.36K | -458.03K | -420.58K | -204.83K | -165.02K | -121.82K | -126.84K | -49.33K | -78.91K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -755K | -599.36K | -458.03K | -420.58K | -204.83K | -165.02K | 7.63M | -7.88M | -48.93K | -107.72K |
Financing activities | ||||||||||
Common Stock Issued | 34.17M | 24.68M | 35.76M | 27.15M | 41.08M | 28.50M | 11.71M | 44.47M | 5.86M | 2.71M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -276K | -90.05K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 44.20M | 26.09M | 35.76M | 27.15M | 41.08M | 28.50M | 11.71M | 44.47M | 5.86M | 2.71M |
Net Change In Cash | 6.83M | 24.65M | -10.65M | -14.65M | 21.79M | -6.85M | -14.96M | 23.71M | -1.89M | -5.14M |
Cash at end of period | 32.30M | 25.46M | 814.49K | 11.47M | 26.13M | 4.33M | 11.19M | 26.16M | 2.44M | 4.64M |
| Data source | Data source | Data source |